Alpine Immune Sciences Inc (ALPN)
64.60
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
64.60
0.00 (0.00%)
After-Hours: 20:00
Alpine Immune Sciences Cash from Investing (TTM): -55.56M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -55.56M |
September 30, 2023 | -50.76M |
June 30, 2023 | -24.43M |
March 31, 2023 | -47.20M |
December 31, 2022 | -113.35M |
September 30, 2022 | -9.734M |
June 30, 2022 | -98.04M |
March 31, 2022 | -83.74M |
December 31, 2021 | -52.48M |
September 30, 2021 | -145.04M |
June 30, 2021 | -80.69M |
March 31, 2021 | -92.50M |
December 31, 2020 | -72.82M |
September 30, 2020 | 28.42M |
June 30, 2020 | 37.44M |
March 31, 2020 | 10.79M |
December 31, 2019 | 16.76M |
September 30, 2019 | 21.51M |
June 30, 2019 | 26.42M |
Date | Value |
---|---|
March 31, 2019 | 47.35M |
December 31, 2018 | 32.12M |
September 30, 2018 | 24.84M |
June 30, 2018 | -37.57M |
March 31, 2018 | -23.10M |
December 31, 2017 | -29.80M |
September 30, 2017 | -18.51M |
June 30, 2017 | 36.38M |
March 31, 2017 | 24.42M |
December 31, 2016 | 25.30M |
September 30, 2016 | -15.07M |
June 30, 2016 | -58.47M |
March 31, 2016 | -64.35M |
December 31, 2015 | -62.45M |
September 30, 2015 | -35.22M |
June 30, 2015 | -0.087M |
March 31, 2015 | -0.0549M |
December 31, 2014 | -0.004M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-145.04M
Minimum
Sep 2021
37.44M
Maximum
Jun 2020
-41.31M
Average
-50.76M
Median
Sep 2023
Cash from Investing (TTM) Benchmarks
Vertex Pharmaceuticals Inc | -3.142B |
Eliem Therapeutics Inc | 68.98M |
Regeneron Pharmaceuticals Inc | -4.636B |
Vera Therapeutics Inc | -39.43M |
Eyenovia Inc | -3.970M |